Life Sciences Report 2017-2018: Biotech-Pharma-Medtech in Berlin-Brandenburg

The healthcare industries cluster - HealthCapital Berlin-Brandenburg celebrates its 10 years anniversary. However, the tradition of the joint work of the States of Berlin and Brandenburg in the field of biotechnology and medical technology already goes back more than 20 years. During this time, the German capital region developed into one of the most dynamic metropolitan areas in Europe that stands for cosmopolitanism, innovation, creativity, and start-ups.

Dynamism alone, however, is not enough to master a successful future. The capital region is also transforming its dynamic development into high-quality growth in science and industry. In the case of the healthcare industries, it is already a world leader in many areas. This is true for topics such as digital health, as well as structures e.g. the Berlin Institute of Health (BIH). And this is especially true for the many large and small companies that occupy top positions in their respective markets.

The new Life Science Report of the Berlin-Brandenburg region describes development in the pharmaceutical, biotechnology, and medical technology sectors, which once again grew by 7% in the last two years. It also shows exciting new developments and numerous opportunities for cooperation with hospitals, businesses, universities, and networks.

Download: Life Sciences Report 2017-2018: Biotech-Pharma-Medtech in Berlin-Brandenburg (6.537 KB).

Download from eHealthNews.eu: Life Sciences Report 2017-2018: Biotech-Pharma-Medtech in Berlin-Brandenburg (6.537 KB).

Most Popular Now

Almirall Takes a Leap into Dermatology D…

Almirall, S.A. (ALM) has launched its first call for innovation to start-ups focused on dermatology digital health. This initiative is the first step in the creation of an accelerator programme...

The Bristol-Myers Squibb-Pfizer Alliance…

The Bristol-Myers Squibb-Pfizer Alliance and Fitbit announced at the TIME 100 Health Summit in New York that they are working together to help drive timely diagnosis of atrial fibrillation (AFib)...

Philips and Spencer Health Solutions Exp…

Building on their successful partnership providing medication adherence solutions to high-acuity patients in the U.S. Royal Philips (NYSE:PHG, AEX:PHIA), a global leader in health technology, and Spencer Health Solutions announced...

Using Artificial Intelligence to Predict…

Thyroid nodules are small lumps that form within the thyroid gland and are quite common in the general population, with a prevalence as high as 67%. The great majority of...

Bayer Launches LifeHub UK Focused on Art…

Bayer launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing artificial-intelligence-enabled imaging solutions. The new hub is the seventh pillar of Bayer's global network...

AI could Offer Warnings about Serious Si…

The more medications a patient takes, the greater the likelihood that interactions between those drugs could trigger negative side effects, including long-term organ damage and even death. Now, researchers at...

NHS Health Tech Team of the Year Named

A pioneering NHS trust has been recognised at the 2019 HTN Awards for its innovative work using InterSystems technology to help enhance care for hundreds of thousands of patients. North...

Philips and Klinikum Stuttgart Hospital …

Royal Philips (NYSE:PHG, AEX:PHIA), a global leader in health technology, and German Klinikum Stuttgart hospital, the largest provider in the region, announced they have signed a comprehensive 10-year innovation partnership...

Heartbeat Labs Hired Babylon Health's Ch…

The Berlin-based digital health platform Heartbeat Labs hired Chad Jennings as Chief Product Officer (CPO). Chad is a product and design leader with twenty years of experience at the intersection...

Combination of AI & Radiologists mor…

An artificial intelligence (AI) tool - trained on roughly a million screening mammography images - identified breast cancer with approximately 90 percent accuracy when combined with analysis by radiologists, a...

Abbott and Omada Health Partner to Offer…

Abbott (NYSE: ABT) and Omada Health announced today they are partnering to integrate Abbott's revolutionary FreeStyle Libre system, a continuous glucose monitoring (CGM) technology, with Omada Health's pioneering digital care...

First Entirely Digital Clinical Trial En…

As little as a daily ping on your phone can boost physical activity, researchers from the Stanford University School of Medicine and their collaborators report in a new study. The...